Axom raises CHF 800k to accelerate market development of its visual inspection station

Axom Solutions AG, established in 2019, identified a critical gap in the realm of low to medium-scale pharmaceutical production where the use of automated visual inspection solutions for quality control remains limited and outdated.

The Basel-based company has already established itself as a trusted partner to leading pharmaceutical companies, including Novartis and Cenexi, providing counting stations that enable precise reconciliation in their production lines. 

Building upon this success, Axom is now focusing its research and development efforts on visual inspection stations. The station is a flexible, simple, and standardised tool designed to detect particles suspended in injectable medications and identify other production defects. This cutting-edge solution integrates machine learning algorithms, high-quality industrial cameras, and robotics, guaranteeing unparalleled accuracy and performance. The goal is to empower pharmaceutical manufacturers by streamlining operations, reducing errors, and ensuring strict compliance with industry regulations.

Tristan Salomon, the founder of Axom, expressed his excitement regarding the recent investment, stating: "This seed funding will significantly accelerate our market penetration and accelerate the delivery of our revolutionary product to pharmaceutical manufacturers. We are thrilled to have the trust and support of our existing investors, led by Spicehaus Partners AG, as well as new angel investors from SICTIC!”

Daniel Andres, founding partner of Spicehaus Partners AG, comments: ”With the successful completion of its round, Axom is poised to make a lasting impact on the pharmaceutical industry. By offering innovative image analysis solutions and pushing the boundaries of quality assurance, Axom continues to be at the forefront of technological advancements in pharmaceutical manufacturing.” 

(Press release / SK)